Search Results for: immunogenicity

April 21, 2025

Safety and immunogenicity of a virus-like particle Chikungunya virus vaccine.

Publication date: Apr 19, 2025 Concepts Keywords Chikungunya Chikungunya Immunogenicity Immunogenicity Safety Lancet Vaccine Particle Virus Safety Vaccine Virus Original Article

April 21, 2025

Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trial.

Chikungunya Literature

Publication date: Apr 19, 2025 Chikungunya disease is a growing global public health concern. Vimkunya (previously chikungunya virus virus-like particle vaccine, previously PXVX0317) is a single-dose, pre-filled syringe for intramuscular ... Read more

April 21, 2025

Chikungunya virus virus-like particle vaccine safety and immunogenicity in adults older than 65 years: a phase 3, randomised, double-blind, placebo-controlled trial.

Chikungunya Literature

Publication date: Apr 19, 2025 Adults older than 65 years are at increased risk for atypical presentations of chikungunya disease, as well as for severe outcomes including death. In this ... Read more

April 20, 2025April 20, 2025

Safety, immunogenicity, and effectiveness of chikungunya vaccines in pregnant persons, children, and adolescents: a protocol for a living systematic review and meta-analysis.

Chikungunya Literature

Publication date: Apr 18, 2025 Chikungunya virus significantly impacts public health, primarily affecting regions in Africa and the Americas (predominantly Latin America and the Caribbean). Despite the global spread of ... Read more

March 27, 2025March 27, 2025

Growing attention of immunogenicity among patients with autoimmune diseases post-SARS-CoV-2 vaccination: meta-analysis and systematic reviews of the current studies.

Coronavirus Literature

Publication date: Dec 01, 2025 This study aimed to identify the optimal strategy for patients with autoimmune diseases by comparing the immunoreaction and effectiveness of severe acute respiratory syndrome coronavirus ... Read more

March 24, 2025March 24, 2025

Effective preparation and immunogenicity analysis of antigenic proteins for prevention of porcine enteropathogenic coronaviruses PEDV/TGEV/PDCoV.

Coronavirus Literature

Publication date: Mar 21, 2025 Porcine epidemic diarrhea virus (PEDV), transmissible gastroenteritis virus (TGEV) and porcine deltacoronavirus (PDCoV) cause highly contagious gastrointestinal damage to piglets with high coinfection in clinical. ... Read more

March 24, 2025March 24, 2025

Alcohol consumption does not influence SARS-CoV-2 vaccine immunogenicity: A stop the spread Ottawa cohort analysis.

Coronavirus Literature

Publication date: Mar 22, 2025 The effect of alcohol consumption on COVID-19 vaccine immunogenicity was evaluated. Participants from the Stop the Spread Ottawa cohort were categorized by alcohol consumption categorized ... Read more

April 21, 2025

Comprehensive preclinical characterization of IPB29, a pan-coronavirus fusion inhibitor under clinical trials.

Coronavirus Literature

Publication date: May 01, 2025 IPB29 is a lipopeptide-based coronavirus fusion inhibitor with the potent, broad-spectrum antiviral activity, and it has already been advanced to phase III clinical trials for ... Read more

March 27, 2025March 27, 2025

Evaluation of the efficacy of the SARS-CoV-2 vaccine additional and booster doses in immunocompromised patients with multiple sclerosis: the COVACiMS study.

Coronavirus Literature

Publication date: Mar 25, 2025 Studies evaluating COVID-19 primary vaccination with two vaccines reported a blunt response in Multiple Sclerosis (MS) patients under anti-CD20 and sphingosine-1-phosphate (S1P) modulators. An extended ... Read more

March 27, 2025March 27, 2025

Evaluation of the efficacy of the SARS-CoV-2 vaccine additional and booster doses in immunocompromised patients with multiple sclerosis: the COVACiMS study.

Coronavirus Literature